产品中心PRODUCT CENTER
全国热线:027-87561633
位置 | 年龄 | 性别 | 标本部位 | 病理分类 | 病理分级 | TNM_T | TNM_N | TNM_M |
A1,B1 | 75 | F | 乳腺 | 浸润性导管癌 | III | T3 | N0 | M0 |
A2,B2 | 30 | F | 乳腺 | 浸润性导管癌 | I | T3 | N0 | M0 |
A3,B3 | 32 | F | 乳腺 | 浸润性导管癌 | III | T3 | N0 | M0 |
A4,B4 | 29 | F | 乳腺 | 浸润性导管癌 | III | T3 | N0 | M0 |
A5,B5 | 35 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
A6,B6 | 67 | F | 乳腺 | 浸润性小叶癌 | II~III | T4 | N0 | M0 |
A7,B7 | 34 | F | 乳腺 | 浸润性导管癌 | III | T3 | N1 | M0 |
A8,B8 | 54 | F | 乳腺 | 浸润性导管癌 | II | T2 | N2 | M0 |
A9,B9 | 53 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
A10,B10 | 47 | F | 乳腺 | 浸润性导管癌 | II~III | T2 | N2 | M0 |
A11,B11 | 48 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
A12,B12 | 40 | F | 乳腺 | 浸润性小叶癌 | II~III | T2 | N0 | M0 |
C1,D1 | 44 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
C2,D2 | 79 | F | 乳腺 | 浸润性导管癌 | II | T2 | N1 | M0 |
C3,D3 | 57 | F | 乳腺 | 浸润性导管癌 | II | T2 | N1 | M0 |
C4,D4 | 43 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
C5,D5 | 43 | F | 乳腺 | 浸润性导管癌 | III | T3 | N0 | M0 |
C6,D6 | 50 | F | 乳腺 | 浸润性导管癌 | III | T2 | N1 | M0 |
C7,D7 | 40 | F | 乳腺 | 浸润性导管癌 | II | T2 | N1 | M0 |
C8,D8 | 30 | F | 乳腺 | 浸润性导管癌 | II | T2 | N1 | M0 |
C9,D9 | 72 | F | 乳腺 | 浸润性导管癌 | I~II | T2 | N1 | M0 |
C10,D10 | 44 | F | 乳腺 | 浸润性导管癌 | II | T2 | N1 | M0 |
C11,D11 | 30 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
C12,D12 | 44 | F | 乳腺 | 浸润性导管癌 | I | T2 | N0 | M0 |
E1,F1 | 37 | F | 乳腺 | 浸润性导管癌 | II | T4 | N1 | M0 |
E2,F2 | 49 | F | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
E3,F3 | 79 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
E4,F4 | 45 | F | 乳腺 | 浸润性导管癌 | II~III | T2 | N0 | M0 |
E5,F5 | 46 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
E6,F6 | 34 | F | 乳腺 | 浸润性小叶癌 | II | T2 | N1 | M0 |
E7,F7 | 40 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
E8,F8 | 64 | F | 乳腺 | 浸润性导管癌 | II | T2 | N1 | M0 |
E9,F9 | 36 | F | 乳腺 | 浸润性导管癌 | III | T2 | N3 | M0 |
E10,F10 | 59 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
E11,F11 | 50 | F | 乳腺 | 浸润性小叶癌 | II | T2 | N0 | M0 |
E12,F12 | 36 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
G1,H1 | 38 | F | 乳腺 | 浸润性导管癌 | II | T2 | N3 | M0 |
G2,H2 | 35 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
G3,H3 | 76 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |
G4,H4 | 34 | F | 乳腺 | 浸润性导管癌 | II | T2 | N1 | M0 |
G5,H5 | 29 | F | 乳腺 | 浸润性导管癌 | II | T3 | N0 | M0 |
G6,H6 | 57 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
G7,H7 | 39 | F | 乳腺 | 浸润性导管癌 | III | T2 | N1 | M0 |
G8,H8 | 41 | F | 乳腺 | 浸润性导管癌 | II | T2 | N2 | M0 |
G9,H9 | 38 | F | 乳腺 | 浸润性导管癌 | III | T2 | N1 | M0 |
G10,H10 | 65 | F | 乳腺 | 浸润性导管癌 | III | T2 | N0 | M0 |
G11,H11 | 36 | F | 乳腺 | 浸润性小叶癌 | II | T3 | N0 | M0 |
G12,H12 | 34 | F | 乳腺 | 浸润性导管癌 | II | T2 | N0 | M0 |